Dose Response to Hydrochlorothiazide in Hypertensives Receiving A Calcium Channel Blocker

Michael G. Ziegler, Elisabeth Lernhardt, Veronika Solt-Buzsaki

Clinical and Experimental Hypertension Part A Theory and Practice · 1988 · 16 citations · 13 references

Concepts

Abstract

Seven hypertensive patients receiving the dihydropyridine calcium channel blocking agent nicardipine were given placebo, 6.25, 12.5, 25 and 50 mg hydrochlorothiazide (HCTZ) in a randomized crossover design. Blood pressure (BP) decreased by about 7/3 mmHg irregardless of dose. In contrast, potassium, glucose and uric acid increased in a dose-dependent fashion. The hypokalemic and hyperglycemic responses at 50 mg were larger than usually seen with HCTZ. Low doses of HCTZ provided a modest antihypertensive effect, but 25 and 50 mg of HCTZ were no more effective in lowering BP and gave unusually large metabolic side effects when combined with a calcium channel blocker.

References

13